← Leaderboards
Mark S Anderson
University Of California, San Francisco
$96,401,564
Attributed
$158,908,715
Total exposure
28
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $43.2M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$176,127,619 · 31
By mechanism
UM1$109,607,005 · 1
P01$25,421,127 · 16
T32$14,322,053 · 1
R01$12,890,245 · 6
U01$7,428,209 · 3
R37$3,636,250 · 1
Top collaborators
- Jane Hoyt Buckner8 shared
- Matthias Hebrok8 shared
- Audrey Parent5 shared
- Megan Sykes5 shared
- Jeffrey A Bluestone4 shared
- Michael S German4 shared
- Clifford A Lowell4 shared
- Abhimanyu Garg2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Michael R Waterfield$3,087,801
- Jason G. Cyster$29,153,268
- Mickie H Cheng$623,588
- Anthony Shum$8,473,492
- Tippi Mackenzie$11,944,783
Others in their field
Top investigators on “Autoimmunity”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$303,553,812
- Barton F Haynes · Duke University$175,178,961
- Jeffrey P Krischer · University Of South Florida$145,926,425
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$84,342,024
- Robert S Negrin · Stanford University$48,464,292
- Lynette Keyes-Elstein · Rho Federal Systems Division, Inc.$41,304,871
Research focus
AutoimmunityImmune ToleranceT-LymphocyteAutoimmune DiseasesCellsInsulin-Dependent Diabetes MellitusAntigensGeneticThymus GlandAutoantigensGenerationsAutoimmune ProcessGenesComplexMediatingPreventSyndromeProgramsAnimalsAffectTransgenic OrganismsRegulatory T-LymphocyteAnimal ModelDiabetes Mellitus
Grant awards (131)
Immune Tolerance Network$27,297,773
UM1 · FY2025 · AI
Immune Tolerance Network$5,707,872
UM1 · FY2025 · AI
UCSF Type 1 Diabetes Research Center$1,835,461
P30 · FY2025 · DK · contact PI
STAT3 variants as a rheostat of immune tolerance$1,712,050
P01 · FY2025 · AI · contact PI
Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes$852,465
U01 · FY2025 · DK
Project-003$737,560
P01 · FY2025 · AI · contact PI
Autoimmune Basis of Acquired Lipodystrophies$677,951
R01 · FY2025 · DK
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity$660,472
R01 · FY2025 · AI · contact PI
Tuning peptide specifities for T cell tolerance in Type 1 diabetes$461,240
R01 · FY2025 · DK · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$403,750
R37 · FY2025 · AI · contact PI
Project-002$384,784
P01 · FY2025 · AI · contact PI
Administrative Core (with Enrichment Program)$367,093
P30 · FY2025 · DK · contact PI
Core-002$257,099
P01 · FY2025 · AI · contact PI
Core-001$255,650
P01 · FY2025 · AI · contact PI
Admin-Core-001$76,957
P01 · FY2025 · AI · contact PI
Immune Tolerance Network$26,502,056
UM1 · FY2024 · AI
Immune Tolerance Network UM1 2023 Supplement$7,500,000
UM1 · FY2024 · AI
Immune Tolerance Network-NIDDK 2024 Supplement$2,642,000
UM1 · FY2024 · AI
STAT3 variants as a rheostat of immune tolerance$1,765,357
P01 · FY2024 · AI · contact PI
Immune Tolerance Network: SUNBEAM Multi-year Supplement$1,000,013
UM1 · FY2024 · AI
Autoimmune Basis of Acquired Lipodystrophies$673,344
R01 · FY2024 · DK
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity$660,723
R01 · FY2024 · AI · contact PI
Tuning peptide specifities for T cell tolerance in Type 1 diabetes$442,995
R01 · FY2024 · DK · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$403,750
R37 · FY2024 · AI · contact PI
Project 2: STAT3 as a trigger for T1D$403,750
P01 · FY2024 · AI · contact PI
Core A: Mouse Core$241,130
P01 · FY2024 · AI · contact PI
Administrative Core$80,750
P01 · FY2024 · AI · contact PI
Immune Tolerance Network$32,108,233
UM1 · FY2023 · AI
Immune Tolerance Network$6,849,058
UM1 · FY2023 · AI
STAT3 variants as a rheostat of immune tolerance$1,765,585
P01 · FY2023 · AI · contact PI
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity$666,258
R01 · FY2023 · AI · contact PI
Tuning peptide specifities for T cell tolerance in Type 1 diabetes$468,463
R01 · FY2023 · DK · contact PI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems$425,000
U01 · FY2023 · DK
Thymic medullary epithelial cell turnover and control of immune tolerance$403,750
R37 · FY2023 · AI · contact PI
Core A: Mouse Core$241,130
P01 · FY2023 · AI · contact PI
Project 2: STAT3 as a trigger for T1D$175,435
P01 · FY2023 · AI · contact PI
Administrative Core$80,750
P01 · FY2023 · AI · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$20,000
R37 · FY2023 · AI · contact PI
STAT3 variants as a rheostat of immune tolerance$1,765,790
P01 · FY2022 · AI · contact PI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems$951,710
U01 · FY2022 · DK
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity$646,691
R01 · FY2022 · AI · contact PI
Tuning peptide specifities for T cell tolerance in Type 1 diabetes$449,529
R01 · FY2022 · DK · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$403,750
R37 · FY2022 · AI · contact PI
Project 2: STAT3 as a trigger for T1D$403,750
P01 · FY2022 · AI · contact PI
Core A: Mouse Core$241,130
P01 · FY2022 · AI · contact PI
Administrative Core$80,750
P01 · FY2022 · AI · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$20,000
R37 · FY2022 · AI · contact PI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems$951,710
U01 · FY2021 · DK
Thymic medullary epithelial cell turnover and control of immune tolerance$396,250
R37 · FY2021 · AI · contact PI
Medical Scientist Training Program$1,671,965
T32 · FY2020 · GM · contact PI
Disruption of T cell tolerance in type 1 diabetes$1,570,677
P01 · FY2020 · AI · contact PI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems$951,344
U01 · FY2020 · DK
Thymic medullary epithelial cell turnover and control of immune tolerance$396,250
R37 · FY2020 · AI · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$373,649
P01 · FY2020 · AI · contact PI
Core A - Animal core$230,368
P01 · FY2020 · AI · contact PI
Program Project Administrative Core$75,060
P01 · FY2020 · AI · contact PI
Medical Scientist Training Program$1,655,657
T32 · FY2019 · GM · contact PI
Disruption of T cell tolerance in type 1 diabetes$1,581,183
P01 · FY2019 · AI · contact PI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems$982,420
U01 · FY2019 · DK
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2019 · DK · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$396,250
R37 · FY2019 · AI · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$373,672
P01 · FY2019 · AI · contact PI
Core A - Animal core$224,203
P01 · FY2019 · AI · contact PI
Building skills in translation through hands-on experience in patient-inspired scientific inquiry$86,400
T32 · FY2019 · GM · contact PI
Program Project Administrative Core$74,734
P01 · FY2019 · AI · contact PI
Medical Scientist Training Program$1,638,666
T32 · FY2018 · GM · contact PI
Disruption of T cell tolerance in type 1 diabetes$1,600,832
P01 · FY2018 · AI · contact PI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2018 · DK · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$396,250
R37 · FY2018 · AI · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$378,316
P01 · FY2018 · AI · contact PI
Developing eTACs as a Novel Method of Tolerance in Type 1 Diabetes$344,738
R01 · FY2018 · DK · contact PI
Core A - Animal core$226,990
P01 · FY2018 · AI · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$158,411
P01 · FY2018 · AI · contact PI
Disruption of T cell tolerance in type 1 diabetes$158,411
P01 · FY2018 · AI · contact PI
Program Project Administrative Core$75,663
P01 · FY2018 · AI · contact PI
Disruption of T cell tolerance in type 1 diabetes$1,629,068
P01 · FY2017 · AI · contact PI
Medical Scientist Training Program$1,622,078
T32 · FY2017 · GM · contact PI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2017 · DK · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$396,250
R37 · FY2017 · AI · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$384,988
P01 · FY2017 · AI · contact PI
Developing eTACs as a Novel Method of Tolerance in Type 1 Diabetes$344,738
R01 · FY2017 · DK · contact PI
Core A - Animal core$153,995
P01 · FY2017 · AI · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$143,143
P01 · FY2017 · AI · contact PI
Disruption of T cell tolerance in type 1 diabetes$143,143
P01 · FY2017 · AI · contact PI
Program Project Administrative Core$76,998
P01 · FY2017 · AI · contact PI
Disruption of T cell tolerance in type 1 diabetes$1,691,347
P01 · FY2016 · AI · contact PI
Medical Scientist Training Program$1,605,904
T32 · FY2016 · GM · contact PI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2016 · DK · contact PI
Project 1 - Central thymic tolerance as a major checkpoint in T1D$396,250
P01 · FY2016 · AI · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$386,250
R01 · FY2016 · AI · contact PI
Developing eTACs as a Novel Method of Tolerance in Type 1 Diabetes$344,738
R01 · FY2016 · DK · contact PI
Core A - Animal core$252,375
P01 · FY2016 · AI · contact PI
Program Project Administrative Core$79,250
P01 · FY2016 · AI · contact PI
Medical Scientist Training Program$1,638,386
T32 · FY2015 · GM · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$386,250
R01 · FY2015 · AI · contact PI
Developing eTACs as a novel method of tolerance in Type 1 Diabetes$344,466
R01 · FY2015 · DK · contact PI
Medical Scientist Training Program$1,388,926
T32 · FY2014 · GM · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$386,250
R01 · FY2014 · AI · contact PI
Developing eTACs as a novel method of tolerance in Type 1 Diabetes$343,107
R01 · FY2014 · DK · contact PI
Medical Scientist Training Program$1,374,061
T32 · FY2013 · GM · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$363,075
R01 · FY2013 · AI · contact PI
Aire-defieciency as a novel model of uveitis$352,260
R01 · FY2013 · EY · contact PI
Medical Scientist Training Program$44,325
T32 · FY2013 · GM · contact PI
Medical Scientist Training Program$1,551,360
T32 · FY2012 · GM · contact PI
Thymic medullary epithelial cell turnover and control of immune tolerance$386,250
R01 · FY2012 · AI · contact PI
Aire-defieciency as a novel model of uveitis$370,800
R01 · FY2012 · EY · contact PI
Medical Scientist Training Program$44,325
T32 · FY2012 · GM · contact PI
Aire-defieciency as a novel model of uveitis$370,800
R01 · FY2011 · EY · contact PI
Aire-defieciency as a novel model of uveitis$386,250
R01 · FY2010 · EY · contact PI
Control of autoimmunity by central tolerance$294,039
P01 · FY2010 · AI · contact PI
Animals$260,663
P01 · FY2010 · AI · contact PI
Aire-defieciency as a novel model of uveitis$367,778
R01 · FY2009 · EY · contact PI
Control of autoimmunity by central tolerance$288,360
P01 · FY2009 · AI · contact PI
Animals$255,635
P01 · FY2009 · AI · contact PI
Aire-defieciency as a novel model of uveitis$78,129
R01 · FY2009 · EY · contact PI
Aire-defieciency as a novel model of uveitis$360,423
R01 · FY2008 · EY · contact PI
Control of autoimmunity by central tolerance$279,962
P01 · FY2008 · AI · contact PI
Animals$248,186
P01 · FY2008 · AI · contact PI
Aire-defieciency as a novel model of uveitis$367,778
R01 · FY2007 · EY · contact PI
Control of autoimmunity by central tolerance$278,681
P01 · FY2007 · AI · contact PI
Animals$258,272
P01 · FY2007 · AI · contact PI
Aire-defieciency as a novel model of uveitis$49,900
R01 · FY2007 · EY · contact PI
Aire-defieciency as a novel model of uveitis$369,849
R01 · FY2006 · EY · contact PI
Control of autoimmunity by central tolerance$277,801
P01 · FY2006 · AI · contact PI
Animals$257,395
P01 · FY2006 · AI · contact PI
Role of the AIRE Gene in the Development of Autoimmunity$125,010
K08 · FY2006 · DK · contact PI
Aire-defieciency as a novel model of uveitis$378,750
R01 · FY2005 · EY
Role of the AIRE Gene in the Development of Autoimmunity$126,090
K08 · FY2005 · DK
Role of the AIRE Gene in the Development of Autoimmunity$125,010
K08 · FY2004 · DK
Role of the AIRE Gene in the Development of Autoimmunity$123,290
K08 · FY2003 · DK
Role of the AIRE Gene in the Development of Autoimmunity$120,776
K08 · FY2002 · DK